ESC 365 - Elamipretide, to block mitochondrial dysfunction?

HFA Premium Access

Elamipretide, to block mitochondrial dysfunction?

Session: Upcoming and novel drugs in heart failure

Topic: Drugs, Drug Targets

Speaker: Professor C. Maack (Wuerzburg, DE)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Professor Christoph Maack

University Clinic Wuerzburg, Wuerzburg (Germany)

37 presentations

3 followers

3 more presentations in this session

Targeting cardiac amyloidosis.

Speaker: Professor S. Heymans (Maastricht, NL)

Targeting fibrosis: pirfenidone and beyond.

Speaker: Professor R. De Boer (Rotterdam, NL)

Gene therapy.

Speaker: Professor Y. Pinto (Amsterdam, NL)

Access the full session

Upcoming and novel drugs in heart failure

Speakers: Professor C. Maack, Professor S. Heymans, Professor R. De Boer, Professor Y. Pinto

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources